Bone Loss Active Not Recruiting Phase 2 Trials for Zoledronic acid (DB00399)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02325414Prevention of Bone Loss After Acute SCI by Zoledronic AcidPrevention